Bulk Antibody Production Efficiency Up 10-fold, Production Costs Down “Several-fold” Since 2002: Chugai

Hitoshi Kuboniwa, General Manager, Pharmaceutical Technology Division Chugai Pharmaceutical’s executives revealed on November 21 that the company’s production efficiency of bulk drug substances for antibody drugs has increased 10-fold since 2002, and its production costs of bulk drug substances have...read more